Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

IGF2 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

IGF2 overexpression	Colorectal Cancer	IGF2 overexpression	Colorectal Cancer	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3
IGF2 overexpression	HER2 Positive Breast Cancer	IGF2 overexpression	HER2 Positive Breast Cancer	trastuzumab Resistant: C3 – Early Trials trastuzumab Resistant : C3	trastuzumab Resistant: C3 – Early Trials trastuzumab Resistant : C3
IGF2 overexpression	Hepatocellular Cancer	IGF2 overexpression	Hepatocellular Cancer	BI-836845 Sensitive: D – Preclinical BI-836845 Sensitive : D	BI-836845 Sensitive: D – Preclinical BI-836845 Sensitive : D